116 related articles for article (PubMed ID: 38472166)
1. Serum exosomal miR-3662 down-regulates the expression of RBMS3 to promote malignant progression and gemcitabine resistance of breast cancer cells.
Li X; Chu X; Wang H; Xiang L; Yue X
Chem Biol Drug Des; 2024 Mar; 103(3):e14488. PubMed ID: 38472166
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MEG3 regulates breast cancer proliferation and apoptosis through miR-141-3p/RBMS3 axis.
Dong S; Ma M; Li M; Guo Y; Zuo X; Gu X; Zhang M; Shi Y
Genomics; 2021 Jul; 113(4):1689-1704. PubMed ID: 33845141
[TBL] [Abstract][Full Text] [Related]
3. MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3.
Zhang H; Wang M; Lang Z; Liu H; Liu J; Ma L
Clinics (Sao Paulo); 2022; 77():100115. PubMed ID: 36228497
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway.
Li Y; Fan L; Yan A; Ren X; Zhao Y; Hua B
J Transl Med; 2024 Jan; 22(1):112. PubMed ID: 38282047
[TBL] [Abstract][Full Text] [Related]
5. Circ_0,007,331 Promotes the PTX Resistance and Progression of Breast Cancer via miR-200b-3p/ANLN.
Yang C; Liu L; Gao C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
J Surg Res; 2022 Nov; 279():619-632. PubMed ID: 35926312
[TBL] [Abstract][Full Text] [Related]
6. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
[TBL] [Abstract][Full Text] [Related]
8. Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis.
Chen Z; Xu Z; Wang Q; Wang L; Zhang H; Wang W; Zhao H; Guo Y; Cui J
Cell Cycle; 2023 Oct; 22(20):2211-2228. PubMed ID: 37974391
[TBL] [Abstract][Full Text] [Related]
9. A Novel circ_0104345/miR-876-3p/ZBTB20 Axis Regulates the Proliferation, Migration, Invasion, and Apoptosis of Breast Cancer Cells.
Wu H; Wang A; Wang L; Shi F; Lin F; Cui H
Biochem Genet; 2023 Dec; 61(6):2548-2565. PubMed ID: 37148331
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Wang J; Yang K; Cao J; Li L
Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
[TBL] [Abstract][Full Text] [Related]
11. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer.
Ding L; Xie Z
Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276
[TBL] [Abstract][Full Text] [Related]
12. Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1.
Yang C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
J Obstet Gynaecol Res; 2021 Nov; 47(11):4037-4048. PubMed ID: 34378285
[TBL] [Abstract][Full Text] [Related]
13. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
Liu SC; Cao YH; Chen LB; Kang R; Huang ZX; Lu XS
Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35998226
[TBL] [Abstract][Full Text] [Related]
14. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.
Wang Y; Dong L; Wan F; Chen F; Liu D; Chen D; Long J
Cell Death Dis; 2021 Sep; 12(10):861. PubMed ID: 34552061
[TBL] [Abstract][Full Text] [Related]
15. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion.
Hao C; Sheng Z; Wang W; Feng R; Zheng Y; Xiao Q; Zhang B
Thorac Cancer; 2023 Jun; 14(16):1477-1491. PubMed ID: 37144254
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0097922 promotes tamoxifen resistance and cell malignant behaviour of breast cancer cells by regulating ACTN4 expression via miR-876-3p.
Liang X; Liu X; Song Z; Zhu J; Zhang J
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1257-1269. PubMed ID: 35856314
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
Xia W; Chen W; Ni C; Meng X; Wu J; Yang Q; Tang H; Yuan H; Fang S
Breast Cancer Res; 2023 Jul; 25(1):85. PubMed ID: 37461019
[TBL] [Abstract][Full Text] [Related]
19. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
Zang H; Li Y; Zhang X; Huang G
Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
[TBL] [Abstract][Full Text] [Related]
20. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X; Kong C; Wu Y
Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
